One out of three breast cancers makes an abnormal amount of a protein known as HER-2/new that helps to drive the growth of the cancer. A simple test of breast cancer cells can tell if the cancer is HER-2/new positive. If it does, a new treatment, Herceptin, is available. Herceptin is a targeted therapy that attacks this protein.
U.S. News's featured content providers were not involved in the selection of advertisers appearing on this website, and the placement of such advertisement in no way implies that these content providers endorse the products and services advertised. Disclaimer and a note about your health.
